Accel Research Sites hits COVID trial milestone, continues evolution - Accel Research Sites

Create a Profile

I accept digital forms of communication(Required)
Hidden
Hidden
This field is for validation purposes and should be left unchanged.
Create a Profile
I accept digital forms of communication(Required)
Hidden
Hidden
This field is for validation purposes and should be left unchanged.

Get In Touch Mobile

I accept digital forms of communication(Required)
This field is for validation purposes and should be left unchanged.

FIND A TRIAL NEAR YOU

No location found for this Zip Code

-- or --

No location found for this Location

FIND A TRIAL NEAR YOU

No location found for this Zip Code

-- or --

No location found for this Location
Back
Date Published: 11/02/2022

Accel Research Sites hits COVID trial milestone, continues evolution

As COVID-19 continues to evolve, a research network that supported the fight against it is evolving, too.

One year after enrolling its first patient in a COVID-19 vaccine trial, Accel Research Sites has started 28 COVID-related trials with more than 3,500 patients. And they’re only looking ahead.

“The Accel team has truly been a leader in the fight against COVID-19, recruiting participants and working toward approval on several vaccine, booster and treatment trials,” said Lora Parahovnik, CEO of Accel Research Sites. “I’m incredibly proud of our team, but I know they won’t stop there. With so much attention on clinical research, we’re ready to take the next steps for COVID and beyond.”

Parahovnik said her company worked on trials for five COVID-19 vaccines across five of the network’s locations. Additionally, they have started three pediatric vaccine trials at three locations and have worked on several COVID-19 testing trials.

Now, while the company continues trials for vaccines and pediatric vaccines, Accel is shifting its focus toward COVID-19 treatment trials and trials for booster shots that will likely be needed soon.

Parahovnik said this vast breadth of experience has helped the company create efficiencies in the trial process, preparing the team to take on a wider variety of research in the future. As they continue to push the horizons of science and medicine, she added, they are looking to add experienced team members, physician partners for their network and new pharmaceutical and medical sponsor partners.

“Our team has been on the cutting edge of science through these trials,” Parahovnik said. “As we continue to partner with those with the same goals, we’re also expanding our business horizons.”

Providers interested in joining the Accel network can click here. Sponsors or CROs interested in working with Accel can click here. Individuals interested in joining the Accel team can click here.

Back

Ready to be part of healthcare history? Find the right clinical trial for you.

Get In Touch

I accept digital forms of communication(Required)
This field is for validation purposes and should be left unchanged.
Accessibility Adjustment

Color Adjustment

Orientation Adjustment

Font Size

 

Line height